Hologic Inc.

Bedford, Mass.-based Hologic Inc. has received FDA approval for two of its tests for the human papilloma virus. The company’s HPV HR (high risk) and HPV 16/18 were designed to detect the 14 high-risk types of the virus, known to cause cervical cancer, and to detect types 16 and 18, which are associated with about 70 percent of cervical cancers, respectively.





LATEST NEWS

• Coractive Appoints CEO: People in the News: 5/22/2024
  May 22, 2024
• Sarcura Teams with imec for On-Chip White Blood Cell Detection
  May 22, 2024
• Quantum Sensor Could Increase Quality and Speed of MRI Scans
  May 21, 2024
• Photonic Tech Lights Up IEEE Electronic Components and Technology Conference
  May 21, 2024
• 3D Printing High Quality Optics with Blurred Light
  May 20, 2024
• Photon Momentum Creates Electron Interaction for Use in Optoelectronics
  May 20, 2024
• Quantum State Opens Possibility for Advances in Optoelectronics
  May 17, 2024
• Active Surfaces Secures $5.6M in Funding for Solar Tech: Week in Brief: 5/17/24
  May 17, 2024